PortfoliosLab logoPortfoliosLab logo
XOMA Corporation (XOMAP)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US98419J3059
CUSIP
98419J305
IPO Date
Dec 16, 2020

Highlights

Market Cap
$475.36M
Enterprise Value
$538.99M
EPS (TTM)
$1.86
PE Ratio
14.15
PEG Ratio
0.05
Total Revenue (TTM)
$52.15M
Gross Profit (TTM)
$49.19M
EBITDA (TTM)
$21.29M
Year Range
$24.96 - $30.00
ROA (TTM)
11.63%
ROE (TTM)
37.78%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


XOMA Corporation

Often compared with XOMAP:
XOMAP vs. SCHD

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in XOMA Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

XOMA Corporation (XOMAP) has returned -0.23% so far this year and 10.43% over the past 12 months.


XOMA Corporation

1D
1.90%
1M
1.58%
YTD
-0.23%
6M
3.37%
1Y
10.43%
3Y*
11.33%
5Y*
9.34%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Dec 16, 2020, XOMAP's average daily return is +0.04%, while the average monthly return is +0.82%. At this rate, your investment would double in approximately 7.1 years.

Historically, 75% of months were positive and 25% were negative. The best month was Dec 2023 with a return of +10.5%, while the worst month was Oct 2023 at -6.6%. The longest winning streak lasted 13 consecutive months, and the longest losing streak was 3 months.

On a daily basis, XOMAP closed higher 45% of trading days. The best single day was Dec 18, 2023 with a return of +10.6%, while the worst single day was Oct 27, 2023 at -5.7%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-1.26%-0.54%1.58%-0.23%
20251.22%0.69%0.05%1.56%0.41%0.45%1.06%2.14%1.03%0.58%2.06%0.94%12.86%
20241.48%-0.95%1.36%0.73%1.31%0.83%1.18%-0.01%3.17%1.66%-1.12%0.74%10.81%
20233.86%0.56%-3.04%0.79%-2.97%5.69%0.45%-2.54%0.63%-6.56%5.21%10.48%11.98%
20220.25%-2.05%6.21%0.07%-2.88%1.36%2.83%-1.49%-3.35%-5.51%4.31%3.47%2.56%
20210.96%0.91%1.06%1.82%0.05%4.24%0.53%0.25%3.03%-0.72%-0.34%0.38%12.76%

Benchmark Metrics

XOMA Corporation has an annualized alpha of 10.10%, beta of 0.08, and R² of 0.01 versus S&P 500 Index. Calculated based on daily prices since December 17, 2020.

  • This stock captured 29.70% of S&P 500 Index gains and tended to rise during its downturns (downside capture of -1.24%) — a profile typical of hedging or uncorrelated assets.
  • Beta of 0.08 may look defensive, but with R² of 0.01 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R² of 0.01 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
10.10%
Beta
0.08
0.01
Upside Capture
29.70%
Downside Capture
-1.24%

Return for Risk

Risk / Return Rank

XOMAP ranks 68 for risk / return — better than 68% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


XOMAP Risk / Return Rank: 6868
Overall Rank
XOMAP Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
XOMAP Sortino Ratio Rank: 6262
Sortino Ratio Rank
XOMAP Omega Ratio Rank: 6262
Omega Ratio Rank
XOMAP Calmar Ratio Rank: 7575
Calmar Ratio Rank
XOMAP Martin Ratio Rank: 7474
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for XOMA Corporation (XOMAP) and compare them to a chosen benchmark (S&P 500 Index).


XOMAPBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.81

0.90

-0.09

Sortino ratio

Return per unit of downside risk

1.29

1.39

-0.10

Omega ratio

Gain probability vs. loss probability

1.18

1.21

-0.04

Calmar ratio

Return relative to maximum drawdown

1.92

1.40

+0.52

Martin ratio

Return relative to average drawdown

4.33

6.61

-2.28

Explore XOMAP risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History

XOMA Corporation provided a 8.21% dividend yield over the last twelve months, with an annual payout of $2.16 per share. The company has been increasing its dividends for 4 consecutive years.


7.00%7.50%8.00%8.50%$0.00$0.50$1.00$1.50$2.0020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021
Dividend$2.16$2.16$2.16$2.16$2.14$1.80

Dividend yield

8.21%8.02%8.33%8.49%8.63%6.83%

Monthly Dividends

The table displays the monthly dividend distributions for XOMA Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.54$0.00$0.00$0.54
2025$0.54$0.00$0.00$0.54$0.00$0.00$0.54$0.00$0.00$0.54$0.00$0.00$2.16
2024$0.54$0.00$0.00$0.54$0.00$0.00$0.54$0.00$0.00$0.54$0.00$0.00$2.16
2023$0.54$0.00$0.00$0.54$0.00$0.54$0.00$0.00$0.00$0.54$0.00$0.00$2.16
2022$0.52$0.00$0.54$0.00$0.00$0.54$0.00$0.00$0.54$0.00$0.00$0.00$2.14
2021$0.72$0.00$0.00$0.00$0.54$0.00$0.54$0.00$0.00$0.00$1.80

Dividend Yield & Payout


Dividend Yield

XOMA Corporation has a dividend yield of 8.21%, which means its dividend payment is significantly above the market average.

Payout Ratio

XOMA Corporation has a payout ratio of 17.26%, which is below the market average. This means XOMA Corporation returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the XOMA Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the XOMA Corporation was 14.28%, occurring on Oct 25, 2022. Recovery took 175 trading sessions.

The current XOMA Corporation drawdown is 3.10%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-14.28%Jul 28, 202263Oct 25, 2022175Jul 10, 2023238
-12.49%Jul 13, 202376Oct 27, 202335Dec 18, 2023111
-6.17%Apr 13, 202227May 20, 202239Jul 19, 202266
-5.57%Jan 5, 202653Mar 20, 2026
-4.86%Sep 30, 202194Feb 11, 202227Mar 23, 2022121

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of XOMA Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how XOMA Corporation is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for XOMAP, comparing it with other companies in the Biotechnology industry. Currently, XOMAP has a P/E ratio of 14.1. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for XOMAP compared to other companies in the Biotechnology industry. XOMAP currently has a PEG ratio of 0.1. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for XOMAP relative to other companies in the Biotechnology industry. Currently, XOMAP has a P/S ratio of 8.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for XOMAP in comparison with other companies in the Biotechnology industry. Currently, XOMAP has a P/B value of 5.8. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items